SUMMARY Antithrombin activities in 30 severely malnourished children and 40 normal children were estimated in clotting tests by thrombin neutralisation as anti-Xa and by a heparin antithrombin assay; and by immunodiffusion as cr2-globulin and ozl-antitrypsin. The patients' mean U2-globulin was severely depressed, and there were less marked depletions in mean values for thrombin neutralisation, anti-Xa, and in the heparin antithrombin assay (which showed the flat curve thought to reflect a thrombotic tendency). The a,-antitrypsin values were normal. The findings support the concept of antithrombin as the summation of OZ2-globulin and cx,-antitrypsin (with a2-macroglobulin); and the low values may be related to the high incidence of thrombosis reported in childhood malnutrition, although it was not seen in these patients.
sidered to be the most important naturally occurring thrombin inhibitor in man (Abildgaard, 1967b) . Acquired and hereditary deficiencies are thought to play an important role in thrombosis and intravascular coagulation (Egeberg, 1965; Abildgaard et al., 1970; Bjarke et al., 1974; Marciniak et al., 1974) . The major compartment of AT III is U2-globulin, while o2-macroglobulin and ai-antitrypsin alsa have some antithrombin activity (Abildgaard, 1967a; Lane et al., 1975; Lane and Biggs, 1977) . A close relationship between AT III, heparin cofactor, and anti-Xa has been described (Biggs et al., 1970; Yin et al., 1971; Marciniak, 1973) , while others have ascribed heparin co-factor and AT III activities to the same protein (Monkhouse and Milojevic, 1968) .
There are few studies on antithrombin activities in childhood, and most of the reports refer to the newborn and infants (Biland and Duckert, 1973; Mahasandana and Hathaway, 1973; Bjarke et al., 1974; Weissbach et al., 1974; Teger-Nilsson, 1975 ).
Children reach adult values at about 6 months of age (Teger-Nilsson, 1975) . Low levels might occur in severely malnourished children because of protein deficiency; and a higher incidence of thrombosis has been reported in this group (Loria et al., 1967;  Received for publication 5 March 1979 Jimenez et al., 1970 , 1972 Ruiz-Reyes and Jim6nez (1965) . Anti-Xa was measured in serum by the method of Denson and Bonnar (1973) . Factor X was measured in serum with the chromogenic substrate S 2222 (benzoyl-isoleucine-glutamyl-glycylarginine-paranitroanilide HCl; Kabi).
ANTITHROMBIN AND HEPARIN-ANTITHROMBIN CLOTTING ASSAYS
The antithrombin assay (ATA) and the heparinantithrombin assay (HATA) were performed by the methods of Innerfield et al. (1976) in sera stored at -70' C for two to three months.
The method for antithrombin assay was as follows: 1 Fibrindex thrombin was diluted with isotonic saline until 0 1 ml clotted 0-2 ml of fresh normal plasma at 370C in 15-16 seconds. 2 0-2 ml of the control pool plasma was placed in a glass tube at 370C. 3 0 1 ml of test serum was then added to 0 9 ml of standardized thrombin in a glass tube, mixed thoroughly, and placed in the waterbath to warm for exactly 3 minutes. 4 After 3 minutes' incubation, 0-1 ml was removed from the thrombin-serum mixture and added forcibly to the tube containing 0-2 ml of plasma, and the clotting time was recorded. 5 For comparison ( Fig. 1) , individual results were converted to percentages of the mean control clotting time.
The method for heparin-antithrombin assay was as follows: 1 Fibrindex thrombin was diluted as above to clot normal plasma in 10 5-11 0 seconds. 2 0-2 ml of the control pool plasma was placed in -each of two glass tubes at 370C. bench temperature. 4 0-1 ml of each heparin-serum mixture was then added to 0-9 ml of standardized thrombin, mixed thoroughly, and placed in the waterbath to warm for exactly 2 minutes. 5 After 2 minutes' incubation, 0-1 ml was removed from each thrombin-heparin-serum mixture and added forcibly to one of the tubes containing 0-2 ml of plasma, and the clotting time was recorded. The other thrombin-heparin-serum mixture was then similarly tested. In each case, the 0 5 IU/ml heparin solution was tested first. 6 For comparison (Fig. 1 The distribution of values in the various antithrombin tests for the patients' and the control sera are shown in Fig. 1 , converted to percentages for comparability. The antithrombin and anti-Xa clotting activities show a lower mean value in the patient group, but an even greater difference is seen in the cX2-globulin values. Figure 2 shows the distributions of clotting values in the heparin test; again the patients show lower mean values than the controls. Other coagulation results are shown in Table 3 ; minor prolongations are seen in the mean PT and TT, but there were no gross differences. There was no correlation between the clotting tests and AT III clotting activity among the patients. patients showed no evidence of intravascular coagulation; the platelet counts were within normal limits, and all patients gave normal FDP titres except one which rose only to a titre of 1 in 25. The relation between AT III by clotting assay and the immunological determination of 0X2-globulin for patients and controls is shown in Figure 3 .
Discussion
The normal progressive inhibition of thrombin in plasma is associated with several substances. Lane et al. (1975) found that ct2-globulin accounted for approximately 50y%, and cxi-antitrypsin and a2-macroglobulin each contributed about 25% to the total activity. AT III also inactivates factor Xa in much the same manner as thrombin (Biggs et al., 1970) ; and the binding of heparin to U2-globulin accelerates the neutralisation of both thrombin and factor Xa (Rosenberg, 1975) . Since antithrombin activity is carried out by at least three proteins, many techniques have been used to measure this activity. We have used clotting assays for the inactivation of thrombin and factor Xa, and immunological measurements of 0X2-globulin and oti-antitrypsin; we estimated HATA with two different concentrations of heparin, following the work of Innerfield et al. (1976) , who suggested that prethrombotic and thrombotic patterns could thus be identified.
Studies of AT III have not, to our knowledge, previously been reported in severely malnourished children.
All the antithrombin tests, except oXi-antitrypsin, showed significantly decreased mean levels in the malnourished group. Antithrombin clotting activity and anti-Xa results indicate that the inactivation of thrombin and factor Xa was reduced in these children.
In comparing the various results shown in Fig. 1 , the following points may be made. Firstly, the antithrombin clotting activity and the anti-Xa measurements agree well, supporting the concept (referred to above) that these activities are referable to the same molecule. Secondly, the discrepancy between these activities and 0o2-globulin in the patients is counterbalanced by the normal values found for axl-antitrypsin; it has been pointed out that antithrombin activity is regarded as the summation of Ox2-globulin (c 50%) and oxi-antitrypsin and x2-macroglobulin (each c 25 %), so that in view of our normal al-antitrypsin results it might be anticipated that the mean antithrombin clotting activity in the patients would be higher than their mean 0X2-globulin level. It was unfortunately not possible to estimate c£2-macroglobulin levels.
Children in this study did not develop thrombosis, although a prethrombotic pattern of HATA was found. The high incidence of thrombosis reported by others in malnutrition has been mentioned above. Presumably the actual occurrence of a thrombus depends on precipitating factors which did not affect our patients.
Marked alterations in blood coagulation have been reported in children with severe malnutrition (Merskey and Hansen, 1957; Dorantes et al., 1964; Jimenez et al., 1969; Bello et al., 1971) , but the present series showed only minor alterations.
